Methylphenidate in Children in Brazil

Critical Analysis of Scientific Publications from 2004 to 2014

Authors

  • Fernanda Araújo Gomes Martins Estudante de Graduação 7º semestre do curso de Medicina da Unifenas, Belo Horizonte-MG, Brasil.
  • Ályson Jordan Ladislau Estudante de Graduação 7º semestre do curso de Medicina da Unifenas, Belo Horizonte-MG, Brasil.
  • Manuela Kumaira Vilchez Estudante de Graduação 7º semestre do curso de Medicina da Unifenas, Belo Horizonte-MG, Brasil
  • Gabriella Maciel Fiamoncini Estudante de Graduação 7º semestre do curso de Medicina da Unifenas, Belo Horizonte-MG, Brasil.
  • Marcos de Araújo Nunes Ferreira Estudante de Graduação 7º semestre do curso de Medicina da Unifenas, Belo Horizonte-MG, Brasil.
  • Diandra Marcela Karpinski Estudante de Graduação 10° semestre do curso de Medicina da Unifenas, Belo Horizonte-MG, Brasil.
  • Bianca Beatriz Ohde Dalledone Estudante de Graduação 10° semestre do curso de Medicina da Unifenas, Belo Horizonte-MG, Brasil.
  • Nathan Mendes Souza Médico de Família e Comunidade, Doutor, Professor da Escola de Medicina da Universidade Federal de Ouro Preto e da Unifenas, Belo Horizonte-MG, Brasil.

DOI:

https://doi.org/10.34024/rnc.2015.v23.8022

Keywords:

Methylphenidate, Attention Deficit Disorder with Hyperactivity Disorder, Child, Brazil

Abstract

Introduction. Attention Deficit and Hyperactivity Disorder (ADHD) compromises academic performance, social and family re­lationships in 3 to 7% of Brazilian schoolchildren. Methylphenidate is a mild central nervous system stimulant used to treatment ADHD, with short and long-term effects already described but others are not yet known. Objective. To analyze the Brazilian scientific literature on the effects of Methylphenidate in children diagnosed with ADHD. Method. Systematic review with selection and quality appraisal of in­cluded studies performed by independent reviewers. Inclusion criteria: Brazilian articles addressing students diagnosed with ADHD and in use of Methylphenidate. Exclusion criteria: articles published before 2004 or with samples with other age groups or that did not assess the effects of Methylphenidate usage. Results. Seventeen articles were in­cluded, five with moderate and three with high methodological qual­ity. Conclusions. The evidentiary base produced in Brazil lacks better methodological quality. The production of moderate to high-quality shows heterogeneity of the effects of Methylphenidate. It is necessary to undertake clinical trials and cohorts studies with greater samples, follow-up time, and inclusion of various subtypes of ADHD, and use of more objective methods to evaluate Methylphenidate’s effects in schoolchildren and that also address antidependency effect.

References

Hardman JG, Limbird LE. Goodman & Gilman As Bases Farmacológicas da Terapêutica. 11th ed. New York: McGraw Hill; 2006, 991p.

Psychotropics substances: statistics for 2011(Endereço na Internet). Estados Unidos da América: International Narcotics Control Board (atualizado em 09/2013; citado em 02/2014). Disponível em <http://www.incb.org/incb/en/psychotropicsubstances/technical_reports/technical_reports_2012.html>.

Prescrição e consumo de Metilfenidato no Brasil: identificando riscos para o monitoramento e controle sanitário (Endereço na Internet). Brasil: Agência- Nacional de Vigilância Sanitária, Boletim de Farmacoepidemiologia SNGPC (atualizado em 12/2012; citado em 02/2014). Disponível em: <http://www.anvisa.gov.br/sngpc/boletins/2012/boletim_sngpc_2_2012_corrigido_2.pdf>.

Desidério RCS, Miyazaki MCOS. Transtorno de Déficit de Atenção/Hiperatividade (TDAH): Orientações para a família. Psicol Esc Educ 2007;11:165- 76. http://dx.doi.org/10.1590/S1413-85572007000100018 DOI: https://doi.org/10.1590/S1413-85572007000100018

Santos LF, Vasconcelos LA. Transtorno do Déficit de Atenção e Hiperatividade em Crianças: Uma Revisão Interdisciplinar. Psic Teor Pesq 2010;26:717-24. http://dx.doi.org/10.1590/S0102-37722010000400015. DOI: https://doi.org/10.1590/S0102-37722010000400015

Segura ABJ. El TDHA, Trastorno por Déficit de Atención con Hiperactividad, en las clasificaciones diagnósticas actuales (C.I.E.10, D.S.M.IV–R y C.F.T.M.E.A.–R 2000). Norte Salud Mental 2009;35:30-40.

Andrade ER, Scheuer C. Análise da eficácia do Metilfenidato: usando a versão abreviada do questionário de conners em transtorno de déficit de atenção/ hiperatividade. Arq Neuropsquiatr 2004;62:81-5. http://dx.doi.org/10.1590/S0004-282X2004000100014 DOI: https://doi.org/10.1590/S0004-282X2004000100014

Souza IGS, Serra-Pinheiro MA, Fortes D, Pinna C. Dificuldades no diagnóstico de TDAH em crianças. J Bras Psiquiatr 2007;56(Supl 1):14-8. http://dx.doi.org/10.1590/S0047-20852007000500004 DOI: https://doi.org/10.1590/S0047-20852007000500004

Pastura G, Mattos P. Efeitos colaterais do Metilfenidato. Rev Psiquiatr Clin 2004;31:100-4. http://dx.doi.org/10.1590/S0101-60832004000200006 DOI: https://doi.org/10.1590/S0101-60832004000200006

Damiani D, Damiani D, Casella E. Hiperatividade e déficit de atenção – O tratamento prejudica o crescimento estatural? Arq Bras Endocrinol Metab 2010;54:262-8. http://dx.doi.org/10.1590/S0004-27302010000300003 DOI: https://doi.org/10.1590/S0004-27302010000300003

Itaborahy C, Ortega F. O Metilfenidato no Brasil: uma década de publicações. Cienc Saúde Colet 2013;18:803 16. http://dx.doi.org/10.1590/S1413-81232013000300026 DOI: https://doi.org/10.1590/S1413-81232013000300026

Szobot CM, Romano M. Co-ocorrência entre transtorno de déficit de atenção/ hiperatividade e uso de substâncias psicoativas co-ocorrência entre transtorno de déficit de atenção/hiperatividade e uso de substâncias psicoativas. J Bras Psiquiatr 2007;56(Supl 1):39-44. http://dx.doi.org/10.1590/S0047-20852007000500009 DOI: https://doi.org/10.1590/S0047-20852007000500009

Peixoto ALB, Rodrigues MMP. Diagnóstico e tratamento de TDAH em crianças escolares, segundo profissionais da saúde mental. Aletheia 2008;28:91- 103.

Szobot CM, Ketzer C, Parente MA, Bierderman J, Rohde LA. The acute effect of methylphenidate in Brazilian male children and adolescents with ADHD: A randomized clinical trial. J Atten Dis 2004;8:37-43. http://dx.doi.org/10.1177/108705470400800201 DOI: https://doi.org/10.1177/108705470400800201

Koneski JAS, Casella EB, Agertt F, Ferreira MG. Efficacy and safety of methylphenidate in treating ADHD symptoms in children and adolescents with uncontrolled seizures: A Brazilian sample study and literature review. Epilepsy Rev Neurocienc 2015;23(2):190-204Behav 2011;21:228-32. http://dx.doi.org/10.1016/j.yebeh.2011.02.029 DOI: https://doi.org/10.1016/j.yebeh.2011.02.029

Zeni CP, Tramontina S, Ketzer CR, Pheula GF, Rohde LA. Methylphenidate Combined with Aripiprazole in Children and Adolescent with Bipolar Disorder and Attention-Deficit/Hyperactivity Disorder: A Randomized Crossover Trial. J Child Adoles Psych 2009;24:428-34. http://dx.doi.org/10.1089/cap.2009.0037 DOI: https://doi.org/10.1089/cap.2009.0037

Farias AC, Cunha A, Benko CR, McCracken JR, Costa MT, Faria LG, et al. Manganese in Children with Attention-Deficit/Hyperactivity Disorder: Relationship with Methyphenidate Exposure. J Child Adoles Psych 2010;20:113-8. http://dx.doi.org/10.1089/cap.2009.0073. DOI: https://doi.org/10.1089/cap.2009.0073

Polanczyk G, Farone SV, Bau CHD, Victor MM, Becker K, Pelz R, et al. The impact of individual and methodological factors in the variability of response to methylphenidate in ADHD pharmacogenetic studies from four different continents. Am J Med Genet B Neuropsychiatr Genet 2008;147:1419- 24. http://dx.doi.org/10.1002/ajmg.b.30855 DOI: https://doi.org/10.1002/ajmg.b.30855

Zeni CP, Guimarães AP, Polanczyk GV, Genro JP, Romano T, Hutz MH, et al. No Significant Association Between Response to Methylphenidate and Genes of the Dopaminergic and Serotonergic Systems in a Sample of Brazilian Children With Attention-Deficit/Hyperactivity Disorder. Am J Med Genet 2007;144:391-4. http://dx.doi.org/10.1002/ajmg.b.30474 DOI: https://doi.org/10.1002/ajmg.b.30474

Toassa G. Sociedade Tarja Preta: uma crítica à medicalização de crianças e adolescentes. Rev Psicol 2012;24:429-34. DOI: https://doi.org/10.1590/S1984-02922012000200015

Polanczyk G, Gene C, Genro JP, Guimarães AP, Roman T, Hutz MH, et al. Association of the Adrenergic α2A Receptor Gene With Methylphenida Rev Neurocienc 2015;23(2):190-204 te Improvement of Inattentive Symptoms in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder. Arch Gen Psychiatry 2007;64:218-24. http://dx.doi.org/10.1001/archpsyc.64.2.218 DOI: https://doi.org/10.1001/archpsyc.64.2.218

Cavadas M, Pereira LD, Mattos P. Efeito do Metilfenidato no processamento auditivo em crianças e adolescentes com transtorno do déficit de atenção/ hiperatividade. Arq Neuropsiquiatr 2007;65:138-43. http://dx.doi.org/10.1590/S0004-282X2007000100028 DOI: https://doi.org/10.1590/S0004-282X2007000100028

Ortega F, Barros D, Caliman L, Itaborahy C, Junqueira L, Ferreira CP, et al. A Ritalina no Brasil: produções, discursos e práticas. Interface Comunic Saude Educ 2010;14:499-510. http://dx.doi.org/10.1590/S141432832010005000003

Menegassi M, Mello ED, Guimarães LR, Matte BC, Driemeier F, Pedroso GL, et al. Food intake and serum levels of iron in children and adolescents with attention-deficit/hyperactivity disorder. Rev Bras Psiquiatr 2010;32:132- 8. http://dx.doi.org/10.1590/S1516-44462009005000008 DOI: https://doi.org/10.1590/S1516-44462009005000008

Sucupira ASL, Frank T. Hiperatividade e déficit de atenção. Trat Med Fam Comunid 2012; 2:1924-34.

Rohde LA, Halpern R. Transtorno de déficit de atenção/hiperatividade: atualização. J Pediatr 2004;80(Supl 2):61-70. http://dx.doi.org/10.1590/S0021-75572004000300009 DOI: https://doi.org/10.1590/S0021-75572004000300009

Biederman, J, Mike E, Faraone SV, Braaten E, Doyle A, Spencer T, et al. Influence of Gender on Attention Defcit Hyperactivity Disorder in Children Referred to a Psychiatric Clinic. Am J Psychiatr 2002;159:36-42. http://dx.doi.org/10.1176/appi.ajp.159.1.36 DOI: https://doi.org/10.1176/appi.ajp.159.1.36

Downloads

Published

2015-06-30

Issue

Vol. 23 No. 2 (2015)

Section

Artigos Originais

How to Cite

1.
Martins FAG, Ladislau Ályson J, Vilchez MK, Fiamoncini GM, Ferreira M de AN, Karpinski DM, et al. Methylphenidate in Children in Brazil: Critical Analysis of Scientific Publications from 2004 to 2014. Rev Neurocienc [Internet]. 2015 Jun. 30 [cited 2026 Nov. 11];23(2):190-204. Available from: https://periodicos.unifesp.br/neurociencias/article/view/8022